Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Henan Taloph Pharmaceutical Stock CoSHSE:600222 -5.93%58 Dividend Payout Ratio is 2.80 as of Mar. 2026, which is 748% above its 10-year median of 0.33. GuruFocus rates SHSE:600222 with a GF Score™ of 58/100 and a GF Value™ of ¥4.92 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 445 Drug Manufacturers companies, Henan Taloph Pharmaceutical Stock Co ranks better than 90.79% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Henan Taloph Pharmaceutical Stock Co's Dividend Payout Ratio for the
months ended in Mar. 2026 was 2.80.
The historical rank and industry rank for Henan Taloph Pharmaceutical Stock Co's Dividend Payout Ratio or its related term are showing as below:
SHSE:600222'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.09 Med: 0.33 Max: 0.42
Current: 0.09
During the past 13 years, the highest Dividend Payout Ratio of Henan Taloph Pharmaceutical Stock Co was 0.42. The lowest was 0.09. And the median was 0.33.
SHSE:600222's Dividend Payout Ratio is ranked better than 90.79% of 445
companies
in the Drug Manufacturers industry
Industry Median: 0.38
vs SHSE:600222: 0.09
During the past 13 years, the highest Trailing Annual Dividend Yield of Henan Taloph Pharmaceutical Stock Co was 0.57%. The lowest was 0.11%. And the median was 0.21%.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Henan Taloph Pharmaceutical Stock Co was 20.50% per year. The lowest was 0.00% per year. And the median was 17.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Henan Taloph Pharmaceutical Stock Co Dividend Payout Ratio Related Terms
Henan Taloph Pharmaceutical Stock Co Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Henan Taloph Pharmaceutical Stock Co Dividend Payout Ratio Chart
SHSE:600222 vs ZTS, UTHR: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Henan Taloph Pharmaceutical Stock Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henan Taloph Pharmaceutical Stock Co Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Henan Taloph Pharmaceutical Stock Co's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Henan Taloph Pharmaceutical Stock Co's Dividend Payout Ratio falls into.
Henan Taloph Pharmaceutical Stock Co Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Henan Taloph Pharmaceutical Stock Co (SHSE:600222) has a Dividend Payout Ratio of 2.80 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Henan Taloph Pharmaceutical Stock Co and its competitors. This is 748% above median its historical median of 0.33. Over the past decade, Henan Taloph Pharmaceutical Stock Co's Dividend Payout Ratio has ranged from 0.09 to 0.42. According to the industry distribution chart, Henan Taloph Pharmaceutical Stock Co ranks #41 out of 445 companies in the Drug Manufacturers industry, placing it in the top 9.2%.
Is Henan Taloph Pharmaceutical Stock Co's Dividend Payout Ratio too high?
Henan Taloph Pharmaceutical Stock Co's current Dividend Payout Ratio of 2.80 is 748% above median its 10-year median of 0.33. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 0.42. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Henan Taloph Pharmaceutical Stock Co's value of 2.80 is 636.8% above this industry median. Based on the distribution chart, Henan Taloph Pharmaceutical Stock Co ranks #41 out of 445 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Henan Taloph Pharmaceutical Stock Co has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Henan Taloph Pharmaceutical Stock Co's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Henan Taloph Pharmaceutical Stock Co ranks #41 out of 445 companies for Dividend Payout Ratio. This places Henan Taloph Pharmaceutical Stock Co in the top 9% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.38. Henan Taloph Pharmaceutical Stock Co's value of 2.80 is 636.8% above this benchmark. Historically, Henan Taloph Pharmaceutical Stock Co's own Dividend Payout Ratio has ranged from 0.09 to 0.42 over the past decade. While the company's 10-year median is 0.33 vs. the industry median of 0.38, Henan Taloph Pharmaceutical Stock Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 445 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Henan Taloph Pharmaceutical Stock Co's current Dividend Payout Ratio of 2.80 is 636.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Henan Taloph Pharmaceutical Stock Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henan Taloph Pharmaceutical Stock Co's current Dividend Payout Ratio is 2.80, which is 748% above median its own 10-year median of 0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henan Taloph Pharmaceutical Stock Co stock overvalued right now?
Based on GuruFocus' analysis, Henan Taloph Pharmaceutical Stock Co (SHSE:600222) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥4.92, compared to a current price of ¥7.45 — trading 51.4% above its estimated fair value. The current Dividend Payout Ratio is 2.80, which is 748% above median its 10-year median of 0.33 and 636.8% above the Drug Manufacturers industry median of 0.38. Henan Taloph Pharmaceutical Stock Co's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Henan Taloph Pharmaceutical Stock Co (SHSE:600222), the current Dividend Payout Ratio is 2.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Overvalued in 2026?
Based on GuruFocus' analysis, Henan Taloph Pharmaceutical Stock Co stock appears to be overvalued.
The current stock price of ¥7.45 is trading 51.4% above its estimated GF Value™ of ¥4.92.
GuruFocus considers Henan Taloph Pharmaceutical Stock Co to be Significantly Overvalued.
Key valuation signals for SHSE:600222:
Dividend Payout Ratio: 2.80 (748% above median its 10-year median of 0.33)
GF Value™: ¥4.92 vs. price of ¥7.45 (51.4% above fair value)
Industry Position: 636.8% above the Drug Manufacturers median (#41 of 445)
No single metric tells the full story. See the SHSE:600222 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henan Taloph Pharmaceutical Stock Co Business Description
Henan Taloph Pharmaceutical Stock Co Ltd is a Chinese company engaged in pharmaceutical manufacturing and pharmaceutical research and development services, including pharmaceutical preparations, Chinese herbal medicine slices, and pharmaceutical research and development services. The company's pharmaceutical preparation business is mainly based on oral Chinese medicine preparations, and its treatment areas cover the respiratory system, cardiovascular and cerebrovascular system, digestive system, and nervous system.
58GF Score
Get the complete analysis for SHSE:600222
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600222 has been successfully added to your 
